Annual Bahrain Rheumatology Conference

Pier Luigi Meroni

Pier Luigi Meroni

Pier Luigi Meroni

Director of the Immunorheumatology Research Laboratory – IRCCS Istituto Auxologico Italiano
Italy

Dr. Pier Luigi Meroni graduated from the Milan Medical School and trained in Internal Medicine and Clinical Immunology. He was nominated Full Professor in Internal Medicine and in Rheumatology. Dr Meroni has been the head of the Department of Rheumatology till 2017. He is now the Director of the Immunorheumatology Research Laboratory -IRCCS Istituto Auxologico Italiano.

He has published over 700 papers in peer-reviewed journals, authored and edited seven books, and written 54 book chapters. H-index: 91 (Scopus), 156 (Google Scholar).

He organized the IVth and the XIIth International Congress on Antiphospholipid Antibodies, and he was co-chairman of the Vth International Congress on Autoimmunity.

Dr. Meroni received the 1977 Roussel Prize for age-associated immune-deficit studies, the 2005 EULAR Prize for research on the infectious etiology of anti-phospholipid syndrome, and the 2014 AESKU Prize for life contribution to autoimmunity. He was nominated for the Master of the American College of Rheumatology in 2014. He has been Chairman and then a member of the IUIS/WHO/AF/CDC Committee for the standardization of diagnostic tests for rheumatic diseases, Italian Representative of the European Autoimmunity Standardization Initiative, founder of the IFCC Working Group Harmonization Autoimmune Serology Testing and president of the Forum Interdisciplinare Ricerca Malattie Autoimmuni.

SELECTED PUBLICATIONS (last five years)

Pesce E, Bombaci M, Croci S, Bonacini M, Marvisi C, Ricordi C, Monti S, Muratore F, Abrignani S, Caporali R, Borghi MO, Salvarani C, Villiger PM, Grifantini R, Meroni PL. Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis. Clin Exp Rheumatol. 2024 Jul;42(7):1317-1320. doi: 10.55563/clinexprheumatol/0213qf.

Raschi E, Borghi MO, Tedesco F, Meroni PL. Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones? Rheumatology (Oxford). 2024 Feb 6;63(SI):SI4-SI13. doi: 10.1093/rheumatology/kead603.

Meroni PL, Borghi MO, Amengual O, Atsumi T, Bertolaccini ML, Cohen H, Grossi C, Roubey R, Sciascia S, Tebo A, Willis R, Erkan D, Devreese KMJ. 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase-based antiphospholipid antibody domain-collaborative efforts of Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking and ISTH SSC to harmonize enzyme-linked immunosorbent assay and non-enzyme-linked immunosorbent assay antiphospholipid antibody tests: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. J Thromb Haemost. 2024 Oct 10:S1538-7836(24)00569-5. doi: 10.1016/j.jtha.2024.09.021. Epub ahead of print.

Bossuyt X, De Langhe E, Borghi MO, Meroni PL. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases. Nat Rev Rheumatol. 2020 Dec;16(12):715-726. doi: 10.1038/s41584-020-00522-w

Meroni PL, Borghi MO. Antiphospholipid antibodies and COVID-19 thrombotic vasculopathy: one swallow does not make a summer. Ann Rheum Dis. 2021 Sep;80(9):1105-1107. doi: 10.1136/annrheumdis-2021-220520.

Meroni PL, Borghi MO. Antiphospholipid Antibody Assays in 2021: Looking for a Predictive Value in Addition to a Diagnostic One. Front Immunol. 2021 Sep 21;12:726820. doi: 10.3389/fimmu.2021.726820.

Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019 Oct;78(10):1296-1304. doi: 10.1136/annrheumdis-2019-215213.

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019 Sep;78(9):1151-1159. doi: 10.1136/annrheumdis-2018-214819. Epub 2019 Aug 5

© Copyright - Annual Bahrain Rheumatology Conference